In Luna Diagnostics we harness the power of nanotechnology to advance clinical diagnostics and screening at point of care. Luna Diagnostic’s team of scientists is led by Dr. Warren Chan, who is one of the world’s leading experts in biomedical nanotechnology. Warren Chan was one of the first researchers to demonstrate the utility of using quantum dot nanoparticles for biomedical applications. Over the past 21 years of his research career in the University of Toronto Warren has been working to understand the interaction of nanomaterials with the biological environment and to perfect the nanoparticle design for use as unique biotechnology tools. Luna Diagnostics is now applying this expertise to develop innovative nanotechnology based diagnostic and screening solutions.
Our Vision
To ensure that no medical treatment is prescribed without a personalized clinical diagnosis.
Our Mission
To apply advanced nanotechnology engineering to create a highly multiplexed, rapid, simple and cost-effective point-of-care diagnostic and screening solutions to be used for clinical disease detection and treatment progress monitoring.
Personalized medicine starts with personalized diagnostics. High multiplexing, which is the ability to detect multiple biomarkers in the same test, is critical for guiding therapeutic decisions because it provides a comprehensive and detailed information about a patient's health status. Our aim is to bring the personalized diagnostics to point-of-care to directly provide a comprehensive diagnostic data at the place and time where the treatment decision is made. This will improve patient outcomes by facilitating earlier and personalized disease detection to help guide informed treatment choices.
Our Value
The value of Luna Diagnostics comes from our extensive expertise in the principles of nanomaterial engineering and in-depth understanding of interactions of these materials with biological systems. We apply this knowledge to develop novel diagnostic methods that enhance detection of molecular signatures of diseases. Our competence ensures accuracy and reproducibility of each one of our diagnostic products.